Vincent Nadeem

1.0k total citations
5 papers, 227 citations indexed

About

Vincent Nadeem is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Pathology and Forensic Medicine. According to data from OpenAlex, Vincent Nadeem has authored 5 papers receiving a total of 227 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Molecular Biology, 2 papers in Radiology, Nuclear Medicine and Imaging and 1 paper in Pathology and Forensic Medicine. Recurrent topics in Vincent Nadeem's work include Protein Tyrosine Phosphatases (2 papers), Fibroblast Growth Factor Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Vincent Nadeem is often cited by papers focused on Protein Tyrosine Phosphatases (2 papers), Fibroblast Growth Factor Research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). Vincent Nadeem collaborates with scholars based in Canada and United States. Vincent Nadeem's co-authors include Esther Masih‐Khan, Jaime O. Claudio, James R. Woodgett, Hong-Chang Tang, A. Keith Stewart, Eva Cukerman, Jason Gonçalves, Choong Chin Liew, Zhihua Li and Michael Voralia and has published in prestigious journals such as Blood, Cancer Research and Protein Science.

In The Last Decade

Vincent Nadeem

5 papers receiving 222 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vincent Nadeem Canada 4 133 106 104 40 37 5 227
Johannes M. Waldschmidt Germany 9 149 1.1× 207 2.0× 158 1.5× 45 1.1× 24 0.6× 53 310
MT Petrucci Italy 8 165 1.2× 240 2.3× 153 1.5× 47 1.2× 15 0.4× 15 299
Zuzana Chyra Czechia 11 170 1.3× 127 1.2× 109 1.0× 41 1.0× 25 0.7× 31 279
Simon Steiger Germany 5 96 0.7× 110 1.0× 146 1.4× 82 2.0× 18 0.5× 6 242
Scott VanWier United States 4 167 1.3× 209 2.0× 72 0.7× 30 0.8× 42 1.1× 4 275
Kevin Watanabe‐Smith United States 9 145 1.1× 94 0.9× 69 0.7× 66 1.6× 13 0.4× 13 267
Romanos Sklavenitis‐Pistofidis United States 8 156 1.2× 145 1.4× 127 1.2× 81 2.0× 19 0.5× 28 297
Samuel S. McCachren United States 7 95 0.7× 104 1.0× 98 0.9× 93 2.3× 16 0.4× 9 228
Heather Ogana United States 7 66 0.5× 87 0.8× 66 0.6× 34 0.8× 23 0.6× 16 204
Sunita Philip United States 5 271 2.0× 266 2.5× 228 2.2× 87 2.2× 24 0.6× 8 405

Countries citing papers authored by Vincent Nadeem

Since Specialization
Citations

This map shows the geographic impact of Vincent Nadeem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vincent Nadeem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vincent Nadeem more than expected).

Fields of papers citing papers by Vincent Nadeem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vincent Nadeem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vincent Nadeem. The network helps show where Vincent Nadeem may publish in the future.

Co-authorship network of co-authors of Vincent Nadeem

This figure shows the co-authorship network connecting the top 25 collaborators of Vincent Nadeem. A scholar is included among the top collaborators of Vincent Nadeem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vincent Nadeem. Vincent Nadeem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
Huang, Haiming, Bernard A. Liu, Andrea C. Uetrecht, et al.. (2015). Selection of recombinant anti‐SH3 domain antibodies by high‐throughput phage display. Protein Science. 24(11). 1890–1900. 14 indexed citations
2.
Mason, Jacqueline M., Xunyi Luo, Vincent Nadeem, et al.. (2011). Abstract LB-215: Inhibition of Polo-like kinase 4 as an anti-cancer strategy. Cancer Research. 71(8_Supplement). LB–215. 4 indexed citations
3.
Masih‐Khan, Esther, Suzanne Trudel, Carla Heise, et al.. (2006). MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma. Blood. 108(10). 3465–3471. 54 indexed citations
4.
Masih‐Khan, Esther, Suzanne Trudel, Zhihua Li, et al.. (2005). Macrophage Inflammatory Protein (MIP)-1alpha (CCL3) Is a Downstream Target of FGFR3 and RAS Signaling in Multiple Myeloma.. Blood. 106(11). 251–251. 2 indexed citations
5.
Claudio, Jaime O., Esther Masih‐Khan, Hong-Chang Tang, et al.. (2002). A molecular compendium of genes expressed in multiple myeloma. Blood. 100(6). 2175–2186. 153 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026